Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Zoster (HZ)”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)Looking for participantsNCT04006808
What this trial is testing

Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Who this might be right for
Herpes Zoster
GlaxoSmithKline 184
Not applicableLooking for participantsNCT07732556
What this trial is testing

Midpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain

Who this might be right for
Midpoint Transverse Process to Pleura BlockErector Spinae Plane BlockAcute Herpes Zoster+1 more
Tanta University 90
Early research (Phase 1)Study completedNCT06375512
What this trial is testing

Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Who this might be right for
Herpes Zoster
Shenzhen Shenxin Biotechnology Co., Ltd 150
Large-scale testing (Phase 3)Study completedNCT03439657
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 913
Early research (Phase 1)Study completedNCT04210752
What this trial is testing

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers

Who this might be right for
Prevention of Herpes Zoster (HZ)
EyeGene Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT04128189
What this trial is testing

Shingrix in Renal Transplant Recipients

Who this might be right for
Kidney Transplant Recipient Response to Shingrix VaccineKidney FailureKidney Failure, Chronic+2 more
University of Colorado, Denver 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205796
What this trial is testing

Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Who this might be right for
Herpes Zoster
Shenzhen Shenxin Biotechnology Co., Ltd 480
Not applicableActive Not RecruitingNCT05811754
What this trial is testing

Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,844
Testing effectiveness (Phase 2)Study completedNCT00802464
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 410
Large-scale testing (Phase 3)Study completedNCT01229267
What this trial is testing

Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 1,257
Testing effectiveness (Phase 2)Looking for participantsNCT06932523
What this trial is testing

Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Who this might be right for
Herpes Zoster (HZ)
Shanghai Institute Of Biological Products 645
Not applicableNot Yet RecruitingNCT06798662
What this trial is testing

Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain

Who this might be right for
Herpes Zoster (HZ)
Xiaguang Duan 120
Not applicableNot Yet RecruitingNCT06870877
What this trial is testing

Neuropathic Pain and Traditional Medicine Syndromes in Herpes Zoster: a Cross-Sectional Study

Who this might be right for
Herpes Zoster (HZ)Traditional Chinese Medicine (TCM)
Do Thanh Sang 80
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Large-scale testing (Phase 3)Study completedNCT02045836
What this trial is testing

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Who this might be right for
Herpes ZosterHerpes Zoster Vaccine
GlaxoSmithKline 865
Not applicableLooking for participantsNCT06969417
What this trial is testing

Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia

Who this might be right for
Herpes Zoster (HZ)Post Herpetic Neuralgia (PHN)
CMH Kharian Medical College 50
Large-scale testing (Phase 3)Study completedNCT01777321
What this trial is testing

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT02114333
What this trial is testing

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Who this might be right for
ShinglesHerpes Zoster
University of Colorado, Denver 160
Large-scale testing (Phase 3)Study completedNCT02735915
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT07311148
What this trial is testing

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster (HZ)ShinglesVZV+1 more
Guangzhou Patronus Biotech Co., Ltd. 840
Next Page